The Connecticut Mirror7d
People call GLP-1s life-changing. CT says it can’t afford them.
In general, state Medicaid programs must cover all FDA-approved drugs. But in a handful of cases, including weight loss medications, states get to decide for themselves. Connecticut’s policy ...
Opinion
Opinion: Connecticut’s balanced approach to obesity drug coverage and health care reform
The Department of Social Services remains committed to exploring policy solutions that maximize health outcomes while maintaining fiscal sustainability.
WSHU news6d
Lawmakers, Lamont at odds over Medicaid-covered GLP-1s
GLP-1’s, drugs like Ozempic and Wegovy, cost Connecticut ... Medicaid keep covering them? WSHU: Hi, Katy. You talk about Sarah Makowicki as an example of what's going on with weight loss drugs ...
NBC Connecticut1mon
Yearslong shortage of popular weight-loss and diabetes drugs resolved, FDA says
Get top local stories in Connecticut delivered ... Ozempic, for diabetes, and Wegovy, for weight loss, use the active ingredient semaglutide. All four drugs are part of a GLP-1 class of treatments ...
Hosted on MSN4mon
Medicaid covers GLP-1 weight-loss drugs in just 13 states
Poorer folks' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently allow Medicaid to cover treatment of obesity using ...
The Connecticut Mirror6d
PODCAST: Lawmakers, Lamont at odds over Medicaid-covered GLP-1s
GLP-1’s, drugs like Ozempic and Wegovy, cost Connecticut more than $ ... as an example of what’s going on with weight loss drugs covered by Medicaid. Could you just tell us a little bit about ...